Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.

Cancer gene therapy

Volumn 2, Issue 3, 1995, Pages 183-190

  Sun, T ^a   Kim, T S ^a   Waltz, M R ^a   Cohen, E P ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8 ANTIGEN; DNA; EPITOPE; INTERLEUKIN 2;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CYTOTOXICITY; EXPERIMENTAL NEOPLASM; FIBROBLAST; GENETIC TRANSFECTION; GENETICS; IMMUNIZATION; IMMUNOLOGY; LYMPHOKINE ACTIVATED KILLER CELL; LYMPHOMA; MELANOMA; METABOLISM; MOUSE; NATURAL KILLER CELL; PATHOLOGY; PHYSIOLOGY; SECRETION; SURVIVAL RATE;

ANIMALS; ANTIGENS; ANTIGENS, CD8; CYTOTOXICITY, IMMUNOLOGIC; DNA, NEOPLASM; EPITOPES, T-LYMPHOCYTE; FIBROBLASTS; IMMUNIZATION; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LYMPHOMA; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; SURVIVAL RATE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029365178     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)